11. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24‐hour continuously monitored mean glucose and fasting β‐hydroxybutyrate levels in a phase IIa pilot study. Issue 6 (27th March 2017) Authors: Henry, Robert R.; Dandona, Paresh; Pettus, Jeremy; Mudaliar, Sunder; Xu, John; Hansen, Lars Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 6(2017) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr. Issue 5 (25th November 2013) Authors: Max Andersen, Marie Louise; Nielsen, Lotte B; Svensson, Jannet; Pörksen, Sven; Hougaard, Philip; Beam, Craig; Greenbaum, Carla; Becker, Dorothy; Petersen, Jacob S; Hansen, Lars; Mortensen, Henrik B Journal: Pediatric diabetes Issue: Volume 15:Issue 5(2014:Aug.) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease. Issue 7 (25th April 2022) Authors: Parker, Victoria E. R.; Hoang, Thuong; Schlichthaar, Heike; Gibb, Fraser W.; Wenzel, Barbara; Posch, Maximillian G.; Rose, Ludger; Chang, Yi‐Ting; Petrone, Marcella; Hansen, Lars; Ambery, Philip; Jermutus, Lutz; Heerspink, Hiddo J. L.; McCrimmon, Rory J. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial. Issue 11 (November 2017) Authors: Dandona, Paresh; Mathieu, Chantal; Phillip, Moshe; Hansen, Lars; Griffen, Steven C; Tschöpe, Diethelm; Thorén, Fredrik; Xu, John; Langkilde, Anna Maria Journal: Lancet Issue: Volume 5:Issue 11(2017) Page Start: 864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Erratum to "Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression". (2nd December 2012) Authors: Nielsen, Lotte B.; Wang, Cheng; Sørensen, Kaspar; Bang-Berthelsen, Claus H.; Hansen, Lars; Andersen, Marie-Louise M.; Hougaard, Philip; Juul, Anders; Zhang, Chen-Yu; Pociot, Flemming; Mortensen, Henrik B. Journal: Experimental diabetes research Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Fast and sensitive detection of indels induced by precise gene targeting. Issue 9 (9th March 2015) Authors: Yang, Zhang; Steentoft, Catharina; Hauge, Camilla; Hansen, Lars; Thomsen, Allan Lind; Niola, Francesco; Vester-Christensen, Malene B.; Frödin, Morten; Clausen, Henrik; Wandall, Hans H.; Bennett, Eric P. Journal: Nucleic acids research Issue: Volume 43:Issue 9(2015) Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2. Issue 1 (22nd November 2022) Authors: Catlett, Ian M.; Aras, Urvi; Hansen, Lars; Liu, Yali; Bei, Di; Girgis, Ihab G.; Murthy, Bindu Journal: Clinical and translational science Issue: Volume 16:Issue 1(2023) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Genetic Risk Score Modelling for Disease Progression in New-Onset Type 1 Diabetes Patients: Increased Genetic Load of Islet-Expressed and Cytokine-Regulated Candidate Genes Predicts Poorer Glycemic Control. (20th January 2016) Authors: Brorsson, Caroline A.; Nielsen, Lotte B.; Andersen, Marie Louise; Kaur, Simranjeet; Bergholdt, Regine; Hansen, Lars; Mortensen, Henrik B.; Pociot, Flemming; Størling, Joachim; Hvidoere Study Group on Childhood Diabetes, Other Names: Songini Marco Academic Editor. Journal: Journal of diabetes research Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Genetic Risk Score Modelling for Disease Progression in New-Onset Type 1 Diabetes Patients: Increased Genetic Load of Islet-Expressed and Cytokine-Regulated Candidate Genes Predicts Poorer Glycemic Control. (20th January 2016) Authors: Brorsson, Caroline A.; Nielsen, Lotte B.; Andersen, Marie Louise; Kaur, Simranjeet; Bergholdt, Regine; Hansen, Lars; Mortensen, Henrik B.; Pociot, Flemming; Størling, Joachim; Hvidoere Study Group on Childhood Diabetes, Other Names: Songini Marco Academic Editor. Journal: Journal of diabetes research Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases. (22nd March 2018) Authors: Joshi, Hiren J; Hansen, Lars; Narimatsu, Yoshiki; Freeze, Hudson H; Henrissat, Bernard; Bennett, Eric; Wandall, Hans H; Clausen, Henrik; Schjoldager, Katrine T Journal: Glycobiology Issue: Volume 28:Number 5(2018) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗